![Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines. - Alaska Public Media Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines. - Alaska Public Media](https://www.alaskapublic.org/wp-content/uploads/2022/04/booster-598963b65e002bee8c411fefaea1ee2b8507c81f-600x450.jpg)
Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines. - Alaska Public Media
![Pfizer sticks to U.S., European vaccine production until 'pandemic supply phase' ends | Fierce Pharma Pfizer sticks to U.S., European vaccine production until 'pandemic supply phase' ends | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1615481756/GettyImages-1218961180.jpg/GettyImages-1218961180.jpg?VersionId=2jRBR3ASggy.QHhnMUQObI3OCN.Cobu0)
Pfizer sticks to U.S., European vaccine production until 'pandemic supply phase' ends | Fierce Pharma
![With business support lacking, Ohio Legislature pulls vaccine mandate exemption legislation - Business Daily News - McKnight's Senior Living With business support lacking, Ohio Legislature pulls vaccine mandate exemption legislation - Business Daily News - McKnight's Senior Living](https://www.mcknightsseniorliving.com/wp-content/uploads/sites/3/2021/08/VaccineMandate_GettyImages-1336007365.jpg)
With business support lacking, Ohio Legislature pulls vaccine mandate exemption legislation - Business Daily News - McKnight's Senior Living
![Pfizer, following last year's Chantix recall, pulls blood pressure med in Canada on carcinogen fears | Fierce Pharma Pfizer, following last year's Chantix recall, pulls blood pressure med in Canada on carcinogen fears | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1642193621/PfizerHQsignone.jpg/PfizerHQsignone.jpg?VersionId=dLmAX5qVM6OytlvJwI40i1B_FPQC5FQ_)
Pfizer, following last year's Chantix recall, pulls blood pressure med in Canada on carcinogen fears | Fierce Pharma
![A push–pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses - ScienceDirect A push–pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X11018196-gr1.jpg)